As vaccines are rolled out across the U.S., the light at the end of the tunnel of the coronavirus pandemic is getting brighter. Almost 30% of Americans have received at least one dose of a COVID-19 vaccine, but questions about their efficacy in preventing disease and viral transmission remain. Luckily, one recent study from across the world is reporting positive news about Pfizer (PFE 2.40%) and Moderna's (MRNA -0.58%) vaccines' capabilities.
Here's what new real-world data from Israel tells us about vaccines and transmissibility.
